These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 9321967)

  • 1. Differential effects of aroclors and DDT on growth factor gene expression and receptor tyrosine kinase activity in human breast epithelial cells.
    Shen K; Novak RF
    Adv Exp Med Biol; 1997; 407():295-302. PubMed ID: 9321967
    [No Abstract]   [Full Text] [Related]  

  • 2. NDF/heregulins stimulate expression of the erbB-2 tyrosine kinase growth factor receptor gene in human breast cancer cells.
    Maggiora P; De Bortoli M
    Ann N Y Acad Sci; 1996 Apr; 784():443-7. PubMed ID: 8651595
    [No Abstract]   [Full Text] [Related]  

  • 3. Spontaneous activation and signaling by overexpressed epidermal growth factor receptors in glioblastoma cells.
    Thomas CY; Chouinard M; Cox M; Parsons S; Stallings-Mann M; Garcia R; Jove R; Wharen R
    Int J Cancer; 2003 Mar; 104(1):19-27. PubMed ID: 12532415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of p185c-erbB-2 proto-oncogene expression by antisense oligodeoxynucleotides down-regulates p185-associated tyrosine-kinase activity and strongly inhibits mammary tumor-cell proliferation.
    Brysch W; Magal E; Louis JC; Kunst M; Klinger I; Schlingensiepen R; Schlingensiepen KH
    Cancer Gene Ther; 1994 Jun; 1(2):99-105. PubMed ID: 7621247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of ras p21, p53 and c-erbB-2 in advanced breast cancer and response to first line hormonal therapy.
    Archer SG; Eliopoulos A; Spandidos D; Barnes D; Ellis IO; Blamey RW; Nicholson RI; Robertson JF
    Br J Cancer; 1995 Nov; 72(5):1259-66. PubMed ID: 7577479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DDT stimulates c-erbB2, c-met, and STATS tyrosine phosphorylation, Grb2-Sos association, MAPK phosphorylation, and proliferation of human breast epithelial cells.
    Shen K; Novak RF
    Biochem Biophys Res Commun; 1997 Feb; 231(1):17-21. PubMed ID: 9070211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylation and nuclear exclusion of the forkhead transcription factor FKHR after epidermal growth factor treatment in human breast cancer cells.
    Jackson JG; Kreisberg JI; Koterba AP; Yee D; Brattain MG
    Oncogene; 2000 Sep; 19(40):4574-81. PubMed ID: 11030146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of breast cancer progression and differentiation by the gp30/heregulin [correction of neregulin].
    Staebler A; Sommers C; Mueller SC; Byers S; Thompson EW; Lupu R
    Breast Cancer Res Treat; 1994; 31(2-3):175-82. PubMed ID: 7881097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of mutant p53 and c-erbB-2 proteins and breast tumour take in mice.
    Mehta RR; Graves JM; Warso MA; Das Gupta TK
    Br J Cancer; 1995 Nov; 72(5):1160-4. PubMed ID: 7577462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mRNA expression of the type I growth factor receptors in the human breast cancer cells MCF-7: regulation by estradiol and tamoxifen.
    Revillion F; Pawlowski V; Lhotellier V; Louchez MM; Peyrat JP
    Anticancer Res; 2003; 23(2B):1455-60. PubMed ID: 12820409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transactivation of ErbB-2 induced by tumor necrosis factor alpha promotes NF-kappaB activation and breast cancer cell proliferation.
    Rivas MA; Tkach M; Beguelin W; Proietti CJ; Rosemblit C; Charreau EH; Elizalde PV; Schillaci R
    Breast Cancer Res Treat; 2010 Jul; 122(1):111-24. PubMed ID: 19760502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermal growth factor receptor expression in human malignant glioma: in vitro and in vivo effects of application of monoclonal antibodies to the epidermal growth factor receptor.
    Westphal M; Hamel W; Zirkel D; Herrmann HD; Bilzer T; Reifenberger G; Schober R; Wechsler W; Albert FK; Behnke J
    Recent Results Cancer Res; 1994; 135():171-84. PubMed ID: 8047692
    [No Abstract]   [Full Text] [Related]  

  • 13. Intermediate filament protein expression in normal and malignant human mammary epithelial cells.
    Taylor-Papadimitriou J; Wetzels R; Ramaekers F
    Cancer Treat Res; 1992; 61():355-78. PubMed ID: 1280457
    [No Abstract]   [Full Text] [Related]  

  • 14. Nordihydroguaiaretic acid (NDGA), an inhibitor of the HER2 and IGF-1 receptor tyrosine kinases, blocks the growth of HER2-overexpressing human breast cancer cells.
    Zavodovskaya M; Campbell MJ; Maddux BA; Shiry L; Allan G; Hodges L; Kushner P; Kerner JA; Youngren JF; Goldfine ID
    J Cell Biochem; 2008 Feb; 103(2):624-35. PubMed ID: 17562544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fish oil targets PTEN to regulate NFkappaB for downregulation of anti-apoptotic genes in breast tumor growth.
    Ghosh-Choudhury T; Mandal CC; Woodruff K; St Clair P; Fernandes G; Choudhury GG; Ghosh-Choudhury N
    Breast Cancer Res Treat; 2009 Nov; 118(1):213-28. PubMed ID: 18953692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-erbB-2/ HER-2 upregulates fascin, an actin-bundling protein associated with cell motility, in human breast cancer cell lines.
    Grothey A; Hashizume R; Ji H; Tubb BE; Patrick CW; Yu D; Mooney EE; McCrea PD
    Oncogene; 2000 Oct; 19(42):4864-75. PubMed ID: 11039904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphatidylinositol 3-kinase recruitment by p185erbB-2 and erbB-3 is potently induced by neu differentiation factor/heregulin during mitogenesis and is constitutively elevated in growth factor-independent breast carcinoma cells with c-erbB-2 gene amplification.
    Ram TG; Ethier SP
    Cell Growth Differ; 1996 May; 7(5):551-61. PubMed ID: 8732665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the activated p185erbB2 tyrosine kinase in human epithelial cells leads to MAP kinase activation but does not confer oncogenicity.
    Nowak F; Jacquemin-Sablon A; Pierre J
    Exp Cell Res; 1997 Mar; 231(2):251-9. PubMed ID: 9087165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-cancer effect of metformin by suppressing signaling pathway of HER2 and HER3 in tamoxifen-resistant breast cancer cells.
    Kim J; Lee J; Kim C; Choi J; Kim A
    Tumour Biol; 2016 May; 37(5):5811-9. PubMed ID: 26581908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EGF-receptor tyrosine kinase and 12-lipoxygenase activity regulate expression of 12-lipoxygenase in human tumor cells.
    Hagmann W; Borgers S
    Adv Exp Med Biol; 1997; 407():9-14. PubMed ID: 9321925
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.